Poly-aspirin nanoparticles - Asalyxa Bio
Alternative Names: ASX-100; ASX-101Latest Information Update: 05 Mar 2021
At a glance
- Originator Asalyxa Bio
- Class Analgesics; Antivirals; Nonsteroidal anti-inflammatories; Salicylic acids; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Immunostimulants; Nitric oxide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Adult respiratory distress syndrome